(Q77619680)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

cytomegaloviral disease

1 reference

J Duan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

W Paris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Kibler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Bousquet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Liuzzi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M G Cordingley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

189-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

A severe combined immunodeficiency mutation in the mouse

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Cytomegalovirus and latency: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Pharmacology and clinical use of foscarnet

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Evaluation of new antiviral agents: II. The use of animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Current management of cytomegalovirus disease in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Ganciclovir. An update of its therapeutic use in cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Promising new treatments for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Progressive Murine Cytomegalovirus Disease after Termination of Ganciclovir Therapy in Mice Immunosuppressed by Cyclophosphamide Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Antiviral activity and pharmacokinetics of HOE 602, an acyclic nucleoside, in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900038-2

7 January 2021

10.1016/S0166-3542(98)00038-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9833959%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference